Zhejiang Orient Gene Biotech Co Ltd
SSE:688298

Watchlist Manager
Zhejiang Orient Gene Biotech Co Ltd Logo
Zhejiang Orient Gene Biotech Co Ltd
SSE:688298
Watchlist
Price: 24.9 CNY -1.31% Market Closed
Market Cap: 5B CNY

Wall Street
Price Targets

Price Targets Summary
Zhejiang Orient Gene Biotech Co Ltd

There are no price targets for Zhejiang Orient Gene Biotech Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Zhejiang Orient Gene Biotech Co Ltd Competitors:
Price Targets
BNTX
BioNTech SE
28% Upside
KALV
Kalvista Pharmaceuticals Inc
132% Upside
LXRX
Lexicon Pharmaceuticals Inc
114% Upside
ALEC
Alector Inc
16% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
80% Upside
2480
Beijing Luzhu Biotechnology Co Ltd
34% Upside
NGNE
Neurogene Inc
243% Upside
PASG
Passage Bio Inc
214% Upside

Revenue
Forecast

Revenue Estimate
Zhejiang Orient Gene Biotech Co Ltd

For the last 7 years the compound annual growth rate for Zhejiang Orient Gene Biotech Co Ltd's revenue is 21%. The projected CAGR for the next 3 years is 129%.

21%
Past Growth
129%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Zhejiang Orient Gene Biotech Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Zhejiang Orient Gene Biotech Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhejiang Orient Gene Biotech Co Ltd's stock price target?
Not Available

Zhejiang Orient Gene Biotech Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Zhejiang Orient Gene Biotech Co Ltd's Revenue forecast?
Projected CAGR
129%

For the last 7 years the compound annual growth rate for Zhejiang Orient Gene Biotech Co Ltd's revenue is 21%. The projected CAGR for the next 3 years is 129%.

Back to Top